HCM
REGN icon

Howland Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Howland Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.2M Sell
37,174
-2,171
-6% -$1.48M 0.84% 35
2026
Q1 		$30.4M Buy
39,345
+1,485
+4% +$1.14M 1.2% 26
2025
Q4 		$29.2M Buy
37,860
+2,175
+6% +$1.48M 1.11% 26
2025
Q3 		$20.1M Buy
35,685
+3,890
+12% +$2.2M 0.76% 42
2025
Q2 		$16.7M Buy
31,795
+5,107
+19% +$2.85M 0.68% 45
2025
Q1 		$16.9M Buy
26,688
+11,251
+73% +$7.74M 0.75% 44
2024
Q4 		$11M Buy
15,437
+14,179
+1,127% +$11.9M 0.48% 51
2024
Q3 		$1.32M Sell
1,258
-57
-4% -$63.4K 0.06% 135
2024
Q2 		$1.38M Sell
1,315
-18
-1% -$17.4K 0.07% 121
2024
Q1 		$1.28M Hold
1,333
– – 0.06% 124
2023
Q4 		$1.17M Sell
1,333
-8
-0.6% -$6.59K 0.06% 128
2023
Q3 		$1.1M Sell
1,341
-8
-0.6% -$6.29K 0.06% 124
2023
Q2 		$969K Sell
1,349
-4
-0.3% -$3.08K 0.06% 131
2023
Q1 		$1.11M Sell
1,353
-83
-6% -$62.6K 0.07% 118
2022
Q4 		$1.04M Sell
1,436
-40
-3% -$29.5K 0.06% 121
2022
Q3 		$1.02M Buy
1,476
+532
+56% +$335K 0.07% 120
2022
Q2 		$558K Sell
944
-15
-2% -$9.75K 0.03% 156
2022
Q1 		$670K Buy
959
+90
+10% +$56.9K 0.04% 134
2021
Q4 		$549K Sell
869
-38
-4% -$23.4K 0.03% 147
2021
Q3 		$549K Hold
907
– – 0.03% 158
2021
Q2 		$507K Sell
907
-5
-0.5% -$2.53K 0.03% 167
2021
Q1 		$432K Buy
912
+93
+11% +$45.3K 0.02% 174
2020
Q4 		$396K Hold
819
– – 0.02% 171
2020
Q3 		$458K Hold
819
– – 0.03% 150
2020
Q2 		$511K Sell
819
-60
-7% -$34.1K 0.04% 144
2020
Q1 		$429K Sell
879
-88
-9% -$36.3K 0.04% 144
2019
Q4 		$363K Buy
+967
New +$325K 0.03% 170

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
LI
LMCG Investments Boston, Massachusetts $1.87B AUM 50.61% 1-Year Est. Return

Howland Capital Management's REGN Position: Q2 2026 in Review

Howland Capital Management reduced its Regeneron Pharmaceuticals (REGN) stake by 5.5% in Q2 2026, selling an estimated $1.48M and leaving 37,174 shares worth $23.2M. The position accounts for 0.84% of the portfolio, ranked #35.

Howland Capital Management first reported a position in REGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $30.4M in Q1 2026. 255 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Howland Capital Management held 37,174 shares of Regeneron Pharmaceuticals worth $23.2M as of Q2 2026.
  • Howland Capital Management sold 2,171 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.48M.
  • Regeneron Pharmaceuticals made up 0.84% of Howland Capital Management's portfolio in Q2 2026, its #35 holding.
  • Howland Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Howland Capital Management's Regeneron Pharmaceuticals position peaked at $30.4M in Q1 2026.
  • 255 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Howland Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.